Invenomic Capital Management’s Leggett & Platt LEG Stock Holding History

Invenomic Capital Management’s Portfolio LEG Stock Details LEG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,158,533	Closed	-$21.3M	–	137
2026 Q1	$21.3M	Sell	2,158,533 -278,986	-11%	-$3.19M	0.98%	36
2025 Q4	$26.8M	Buy	2,437,519 +93,213	+4%	+$917K	1.25%	22
2025 Q3	$20.8M	Buy	2,344,306 +717,079	+44%	+$6.83M	1.01%	31
2025 Q2	$14.5M	Sell	1,627,227 -365,092	-18%	-$3.14M	0.82%	43
2025 Q1	$15.8M	Buy	1,992,319 +475,163	+31%	+$4.51M	0.8%	40
2024 Q4	$14.6M	Buy	1,517,156 +595,684	+65%	+$7.13M	0.69%	45
2024 Q3	$12.6M	Buy	921,472 +731,132	+384%	+$9.13M	0.69%	50
2024 Q2	$2.18M	Sell	190,340 -29,115	-13%	-$411K	0.11%	144
2024 Q1	$4.2M	Buy	+219,455	New	+$4.77M	0.22%	105

Other funds holding LEG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FACM

Forest Avenue Capital Management Miami, Florida $2.38B AUM 88.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invenomic Capital Management's LEG Position: Q2 2026 in Review

Invenomic Capital Management sold out of Leggett & Platt (LEG) in Q2 2026, closing a stake of 2,158,533 shares — an estimated $21.3M sold.

Invenomic Capital Management first reported a position in LEG in Q1 2024 and held it in 9 quarters. The position peaked at $26.8M in Q4 2025. 345 funds tracked by Wall St. Rank hold LEG as of Q2 2026.

Invenomic Capital Management reported no remaining Leggett & Platt position as of Q2 2026 after selling out during the quarter.
Invenomic Capital Management sold 2,158,533 Leggett & Platt shares in Q2 2026, an estimated $21.3M.
Invenomic Capital Management first reported a position in Leggett & Platt in Q1 2024 and held it in 9 quarters.
Invenomic Capital Management's Leggett & Platt position peaked at $26.8M in Q4 2025.
345 funds tracked by Wall St. Rank held Leggett & Platt as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.